Servet Bölükbas

13PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Particle physicsMedical infection agents (incl. prions)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Impact of COPD on Outcomes After Pulmonary Metastasectomy: A Propensity-Score Matched Analysis.

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Mar 28, 2026
Radiation Dose-Dependent and -Independent Pulmonary Infiltrates in Patients with High-Grade Pneumonitis After Radiochemotherapy and Durvalumab Consolidation for Stage III NSCLC.

Andreas Herz, Aymane Khouya, Maja Guberina

|Oct 28, 2025
Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression.

Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel

|Apr 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Berta Mosleh, Katharina Sinn, Anna Cho

|Feb 25, 2025
Is CK7 a Prognostic Marker in Pulmonary LCNEC? Evidence from a Limited Cohort Study.

Hruy Menghesha, Donatas Zalepugas, Amina Camo

Pageof 3

Frequent Collaborators

7 joint publications

Martin Schuler

6 joint publications

Fabian Doerr

3 joint publications

Natalie Baldes

3 joint publications

Clemens Aigner